Topic: Biomarkers

The Role of FSH in Prostate Cancer

Marc B. Garnick, MD, addresses the question, “Does Follicle Stimulating Hormone (FSH) effect prostate cancer progression and adverse effects to androgen deprivation therapy (ADT), and should we be modulating it?” He presents evidence for both the pro and con sides of this argument.

Read More

Join the GRU Community

- Why Join? -